RecruitingPhase 3NCT06617325
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Sponsor: UCB Biopharma SRL
Pittsburgh, PA · +62 more sites
3 recruiting lupus studies with a site in Pittsburgh, PA.
Sponsor: UCB Biopharma SRL
Pittsburgh, PA · +62 more sites
Sponsor: Novartis Pharmaceuticals
Pittsburgh, PA · +24 more sites
Sponsor: National Cancer Institute (NCI)
Philadelphia, PA · Pittsburgh, PA · +49 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.